Journal of Clinical Pathways June 23, 2021
Maureen Hennessey, PhD, CPCC, CPHQ Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Introduction

The Centers for Medicare & Medicaid Services (CMS) announced another evaluation report of the Oncology Care Model (OCM) in January 2021,1 covering activities and results for performance periods (PPs) 1 through 5 of 11. In the March 20192 and September 2020editions of this journal section, authors offered observations based on the previous OCM annual reports. This current article builds upon those observations in light of data from this most recent report published in January 2021, focusing on Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department (ED) and hospital use, end-of-life (EOL) care, and medication utilization and selection. Insights gained from this performance evaluation have potential applicability...

Today's Sponsors

ZeOmega
Holon
Transcarent

Today's Sponsors

Crossover Health
Qure4u

Today's Sponsor

Institute for Healthcare Improvement

 
Topics: CMS, Govt Agencies, Insurance, Medicare, Payment Models, Physician, Provider, Survey / Study, Trends, Value Based
Rep. DelBene: How Congress can help deliver right incentives to providers for value-based care
PCORI’s Expanded Mandate Creates New Opportunities for Value Assessment Research
NextGen Access Decision Makers Influencing Impact on Services and Therapies Across the Healthcare Ecosystem
Humana Sets Stage for Kindred Takeover, Remains Hopeful About a 2022 Return to Normalcy
Kindred at Home Deal to Bolster Humana’s Performance Via Value-Based Arrangements